Protective effects of 1α,25-(OH)2D3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture

Neuropharmacology

Volumn 40, Issue 6, 2001, Pages 761-771

  Ibi, M ^a   Sawada, H ^b   Nakanishi, M ^a   Kume, T ^a   Katsuki, H ^a   Kaneko, S ^a   Shimohama, S ^b   Akaike, A ^a  

^a Grad Sch Pharmaceutical Sci   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

1 ,25 (OH)2D3; Dopaminergic neuron; Glutamate; Mesencephalon; Neuroprotection

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CALCIMYCIN; CALCITRIOL; CALCIUM IONOPHORE; COLECALCIFEROL; CYCLOHEXIMIDE; DACTINOMYCIN; GLUTAMIC ACID; HYDROGEN PEROXIDE; NEUROTOXIN; OXIDOPAMINE; PROTEIN SYNTHESIS INHIBITOR; REACTIVE OXYGEN METABOLITE; VITAMIN D RECEPTOR;

ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; FETUS; INCUBATION TIME; MESENCEPHALON; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ADRENERGIC AGENTS; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; GLUTAMIC ACID; HERBICIDES; MESENCEPHALON; NEURONS; OXIDOPAMINE; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 0035005186     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(01)00009-0     Document Type: Article

References (30)

1. Baudet C., Chevalier G., Chassevent A., Canova C., Filmon R., Larra F., Brachet P., Wion D. 1,25-dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. Journal of Neuroscience Research. 46:1996;540-550.
2. Bayne K. Revised guide for the care and use of laboratory animals available. Physiologist. 39:1996;199-208.
3. Derex L., Trouillas P. Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitmain D therapy. Movement Disorder. 12:1997;612-613.
4. Ferret P.J., Soum E., Negre O., Wollman E.E., Fradelizi D. Protective effect of thioredoxin upon NO-mediated cell injurynin THP1 monocytic human cells. Biochemical Journal. 346:2000;759-765.
5. Folgueira M.A., Federico M.H., Katayama M.L., Silva M.R., Brentani M.M. Expression of vitamin D receptor (VDR) in HL-60 cells is differentially regulated during the process of differentiation induced by phorbol ester, retinoic acid or interferon-gamma. Journal of Steroid Biochemistry and Molecular Biology. 66:1998;193-201.
6. Garcion E., Sindji L., Leblondel G., Brachet P., Darcy F. 1,25-dihydroxyvitamin D3 regulates the synthesis of γ-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. Journal of Neurochemistry. 73:1999;859-866.
7. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. Journal of Bone and Mineral Research. 13:1998;325-349.
8. Ibi M., Sawada H., Kume T., Katsuki H., Kaneko S., Shimohama S., Akaike A. Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons. Journal of Neurochemistry. 73:1999;1696-1703.
9. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Movement Disorder. 13(Suppl. 1):1998;24-34.
10. Karasawa M., Hosoi J., Hashiba H., Nose K., Tohyama C., Abe E., Suda T., Kuroki T. Regulation of metallothionein gene expression by 1alpha,25-dihydroxyvitamin D3 in cultured cells and in mice. Proceedings of the National Academy of Sciences of the United States of America. 84:1987;8810-8813.
11. Lee J.H., Youn J.I. The photoprotective effect of 1,25-dihydroxyvitamin D3 on ultraviolet light B-induced damage in keratinocyte and its mechanism of action. Journal of Dermatological Science. 18:1998;11-18.
12. Montoliu C., Monfort P., Carrasco J., Palacios O., capdevila M., Hidalgo J., Felipo V. Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons. Journal of Neurochemistry. 75:2000;266-273.
13. Naveilhan P., Neveu I., Wion D., Brachet P. 1,25-dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. NeuroReport. 7:1996;2171-2175.
14. Neveu I., Naveilhan P., Menaa C., wion D., Brachet P., Garabedian M. Synthesis of 1,25-dihydrovitamin D3 by rat brain microglia in vitro. Journal of Neuroscience Research. 38:1994;214-220.
15. Neveu I., Naveilhan P., Jehan F., Baudet C., Wion D., DeLuca H.F., Metsis M. 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Research of Molecular Brain Research. 24:1994;70-76.
16. Neveu I., Naveilhan P., Baudet C., Brachet P., Metsis M. 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. NeuroReport. 6:1994;124-126.
17. Prüfer K., Veenstrra T.D., Jirikowski G.F., Kumar R. Distribution of 1,25- dihyjdroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. Journal of Chemical Neuroanatomy. 16:1999;135-145.
18. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;4565-4571.
19. Sato Y., Kikuyama M., Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology. 49:1997;1273-1278.
20. +) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon. Journal of Neuroscience Research. 43:1996;55-62.
21. Sawada H., Kawamura T., Shimohama S., Akaike A., Kimura J. Different mechanisms of glutamate-induced neuronal death between dopaminergic and non-dopaminergic neurons in rat mesencephalic culture. Journal of Neuroscience Research. 43:1996;503-510.
22. Sawada H., Shimohama S., Kawamura T., Akaike A., Kitamura Y., Yaniguchi T., Kimura J. Mechanisms of resistance to NO-induced neurotoxicity in cultured rat dopaminergic neurons. Journal of Neuroscience Research. 46:1996;509-518.
23. Sawada H., Ibi M., Kihara T., Urushitani M., Nakanishi M., Akaike A., Shimohama S. Neuroprotective mechanisms of Glial cell line-derived neurotrophic factor in mesencephalic neurons. Journal of Neurochemistry. 74:2000;1175-1184.
24. Takagi Y., Mitsui A., Nishiyama A., Nozaki K., Sono H., Gon Y., Hashimoto N., Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;4131-4136.
25. van Lookeren-Campagne M., Thibodeaux H., van Bruggen N., Cairns B., Gerlai R., Palmer J.T., Williams S.P., Lowe D.G. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;12870-12875.
26. Veenstra T.D., Prüfer K., Koenigsberger C., Brimijioin S.W., Grrande J.P., Kumar R. 1,25-Dihydrovitamin D3 receptor in the central neurvous system of the rat embryo. Brain Research. 804:1998;193-205.
27. Walters M.R. Newly identified actions of the vitamin D endocrine system. Endocrinological Reviews. 13:1992;719-764.
28. Wang Y., Chiang Y.-H., Su T.-P., Hayashi T., Morales M., Hoffer B.J., Lin S.-Z. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology. 39:2000;873-880.
29. Wark J.C. Jr., Tashjian A.H. Vitamin D stimulates prolactin synthesis by GH4C1 cells incubated in chemically defined medium. Endocrinology. 111:1982;1755-1757.
30. Zuddas A., Oberto G., Vaglini F., Fascetti F., Fornai F., Corsini G.U. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. Journal of Neurochemistry. 59:1992;733-739.